Mikra Builds Out Marketing Plan with Jose Bautista, Redesigns Focus Product Packaging
26 juil. 2024 07h00 HE
|
Lifeist Wellness Inc.
Focus marketing plan
Mikra Big Summer Sale On Now, Free Gift with Each Order
18 juil. 2024 07h00 HE
|
Lifeist Wellness Inc.
TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Big Summer Sale Signup; All Mikra Products on Amazon with Prime Shipping
15 juil. 2024 07h00 HE
|
Lifeist Wellness Inc.
Big Summer Sale Signup; All Mikra Products on Amazon with Prime Shipping
Mikra Applies to Health Canada for CELLF 2.0 NPN
08 juil. 2024 07h00 HE
|
Lifeist Wellness Inc.
Mikra Applies to Health Canada for CELLF 2.0 NPN
Lifeist Appoints Andrea Judge CEO of Mikra Cellular Sciences
03 juil. 2024 07h00 HE
|
Lifeist Wellness Inc.
Lifeist Appoints Andrea Judge CEO of Mikra Cellular Sciences
Mikra PROTECT Immune Support Gummy Now Shipping
23 févr. 2024 07h03 HE
|
Lifeist Wellness Inc.
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Mikra Launches New Immune Protect Gummies with Bundle Sales Promotion
20 déc. 2023 07h00 HE
|
Lifeist Wellness Inc.
Mikra launches Protect, a new natural immune support product based on Aronia berries and key vitamins, shipping a free trial bottle with our next 500 order
Mikra to Introduce Innovative Immune Support Gummy
14 déc. 2023 07h00 HE
|
Lifeist Wellness Inc.
Mikra introduces PROTECT, a new natural immune support product based on Aronia berries and key vitamins
Travere Therapeutics Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM Respectively and Presented at the American Society of Nephrology (ASN) Kidney Week 2023
03 nov. 2023 10h46 HE
|
Travere Therapeutics, Inc.
“The totality of data from the PROTECT study demonstrates FILSPARI is effective, safe and has an important place in the IgAN treatment landscape ..."
Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
13 oct. 2023 16h30 HE
|
Travere Therapeutics, Inc.
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsentan in FSGS 11 total abstracts accepted for...